Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients

Background: Although Carbohydrate antigen 19-9 (CA19-9) is considered clinically useful and informative for pancreatic carcinoma (PC), false positive results, and false negative results have restricted its clinical use. Especially missed or delayed diagnosis of PC patients with negative CA19-9 value...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Zhong, Ailing, Qin, Ruihuan, Qin, Wenjun, Han, Jing, Gu, Yong, Zhou, Lei, Zhang, Hongqin, Ren, Shifang, Lu, Renquan, Guo, Lin, Gu, Jianxin
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6402387/
https://ncbi.nlm.nih.gov/pubmed/30873386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00114
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars